You've run your experiments, got your results, and you've been mentally spending -- or at least licensing -- the proceeds of your bulging IP portfolio. But that may have been the easy part, writes Renate Krelle. Before you go any further, here's a checklist of some of the most common patenting pitfalls.

Ethical concerns over issues like the use of embryonic stem cells in research could be addressed in the patent system, a new paper has argued.

US company Affymetrix has told a government panel that patents should not be applied to gene sequences.